|
|
Other links at Articles > Cardiology |
| 3. |
Early Multifactorial Intervention Key in Diabetes
|
|
|
A study looking at early intervention with multiple drug combinations in at-risk patients with type 2 diabetes has shown an absolute risk reduction of 20% in all-cause mortality. Medscape Medical News
|
| 4. |
FDA Grants Additional Indication for Rosuvastatin
|
|
|
AstraZeneca has gained an additional indication in the US for rosuvastatin, as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol. Doctors will now have the option of prescribing rosuvastatin to those with a 10-year Framingham risk of less than 10%; such patients usually just receive advice on lifestyle interventions. Heartwire
|
|
|